Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Dexeus

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Urology|March 1, 1992
Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancerA Sella, C J Logothetis, K Fitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
The Journal of Urology|June 1, 1988
Adjuvant chemotherapy of bladder cancer: a preliminary reportC J Logothetis, D E Johnson, C Chong, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
The Journal of Urology|September 1, 1985
Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastasesC J Logothetis, M L Samuels, S Ogden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
The Journal of Urology|September 1, 1991
Circadian infusion of floxuridine in patients with metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
The Journal of Urology|October 1, 1991
Evidence of malignant features in histologically mature teratomaA Sella, A el Naggar, J Y Ro, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Urology|March 1, 1992
Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancerA Sella, C J Logothetis, K Fitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
The Journal of Urology|June 1, 1988
Adjuvant chemotherapy of bladder cancer: a preliminary reportC J Logothetis, D E Johnson, C Chong, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
The Journal of Urology|September 1, 1985
Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastasesC J Logothetis, M L Samuels, S Ogden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
The Journal of Urology|September 1, 1991
Circadian infusion of floxuridine in patients with metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
The Journal of Urology|October 1, 1991
Evidence of malignant features in histologically mature teratomaA Sella, A el Naggar, J Y Ro, et al.
Pageof 4